Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors. - Abu‐Khalaf, Maysa M.; Baumgart, Megan A.; Gettinger, Scott N.; Doddamane, Indukala; Tuck, David P.; Hou, Shihe; Chen, Nianhang; Sullivan, Catherine; Lezon‐Geyda, Kimberly; Zelterman, Daniel; Hatzis, Christos; Deshpande, Hari; et al. (Cancer (0008543X), 2015)